Arteris just delivered its Q1 2026 earnings — and the stock's 68% rally over the past month has created a striking three-way tension: analysts are sharply raising their targets, insiders are aggressively selling into the strength, and short sellers are rebuilding positions at the fastest weekly pace in months.
The clearest immediate story is the analyst reaction to Q1. The Street sprinted to catch up on May 13. TD Cowen lifted its target from $22 to $40 while maintaining Buy. Rosenblatt went from $20 to $38, also Buy. Jefferies, holding at a more cautious Hold, still nearly doubled its target from $16 to $35. Every move was a raise — not a single cut in the batch — and collectively they moved the consensus mean target to $33.25 against a close of $32.43. The implication is that the Street broadly now sees the stock as fairly priced after the run, with only the Buy-rated analysts still pricing in meaningful further upside. The Benzinga bull case centres on Arteris's IP solutions for AI-driven data movement and the Cycuity acquisition expanding its hardware-security addressable market. Bears flag concentration risk in Automotive, AI/ML, and 5G, plus execution risk on the Cycuity earn-out structure. Q1 revenue beat estimates despite a reported loss, and the company flagged a CFO departure alongside the results — a footnote that bears will keep an eye on heading into the June 2 follow-up event.
Insiders, however, are sending a more cautionary signal. The selling has been persistent, broad, and accelerating into the price strength. Chairman, President and CEO Karel Janac sold 70,000 shares on May 8 at just over $31 — a $2.2 million transaction. That came on top of director-level sales across multiple names: Saiyed Atiq Raza offloaded 90,000 shares for $2.6 million on May 1, and independent director Antonio Viana has been trimming steadily since April, selling in three separate tranches totalling 60,000 shares. The COO sold in mid-April. Net insider activity over 90 days amounts to roughly 444,000 shares sold — net proceeds of $10.9 million. No offsetting purchases appear in the record. This is not a single executive managing tax obligations; it is a cluster of senior figures reducing exposure across the board into a once-in-a-year price spike.
The short-selling community is arriving at a similar cautious read. Short interest climbed nearly 39% over the week to 3.2% of the free float — a sharp rebuild from the ~1 million share level that had prevailed through most of April and early May. The single-day jump on May 12 alone was 5.5%. At this level, 3.2% of float is not extreme by absolute standards, but the direction and velocity of the move post-earnings is notable. The borrow market remains well supplied: availability has ticked up slightly, cost to borrow is a modest 0.54% annualised, and the 52-week peak utilisation of 16.5% is far above the current 5.4% reading. That combination — sharply rising short interest but still-cheap, available borrow — suggests new shorts are entering with ease, not scrambling to cover. The ORTEX short score has crept up to 36.4 from the mid-32s a week ago, though it remains well below alarm-bell territory.
Options positioning reinforces the hedging theme without screaming conviction. The put/call ratio is running at 0.15, above its 20-day average of 0.11 and roughly 1.2 standard deviations elevated — nowhere near the 52-week high of 0.19, but meaningfully higher than the sub-0.09 readings that dominated late April. The shift happened precisely in the days surrounding the earnings print, which suggests traders are buying some downside protection on the gap higher rather than outright wagering on a reversal. The stock's own EPS surprise factor ranks in the 91st percentile of the universe — suggesting a strong history of beating estimates — and forward EPS growth sits in the 90th percentile. Those are the numbers that justify the analyst enthusiasm. The factor model reads neutral-to-cautious on short positioning (49th percentile short-score rank), consistent with a stock that is shorted but not yet squeezed.
Prominent institutional holders have generally been adding rather than trimming. BlackRock, Vanguard, Franklin Resources, State Street, and Goldman Sachs Asset Management all reported net additions in their most recent filings. TIAA added over 659,000 shares. These are mostly passive or broad-active flows, but the direction contrasts with insider behaviour. Founder and CEO Janac remains the largest holder at just under 20% of shares outstanding — his May 8 sale was large in dollar terms but modest relative to his total stake.
What to watch next: the June 2 event will be scrutinised for any tone shift on the CFO transition and on whether the Cycuity integration is tracking ahead of the earn-out targets that underpin the bull case.
See the live data behind this article on ORTEX.
Open AIP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
